Robert H Nicholson, MD in Skowhegan, ME - Ophthalmology

Robert H Nicholson, MD is a Ophthalmology physician based in Skowhegan, Maine. Robert H Nicholson is licensed to practice in Maine (license number 007644) and his current practice location is 56 Main Street, Skowhegan, Maine. He can be reached at his office (for appointments etc.) via phone at (207) 474-8850.

NPI number for Robert H Nicholson is 1659481885 and his current mailing address is Po Box 66, Skowhegan, Maine. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1659481885.

Contact Information

	Robert H Nicholson, MD
	56 Main Street, Skowhegan, ME 04976
	(207) 474-8850
	(207) 474-7372

Physician's Profile

Full Name	Robert H Nicholson
Gender	Male
Speciality	Ophthalmology
Location	56 Main Street, Skowhegan, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1659481885
Provider Enumeration Date: 08/30/2006
Last Update Date: 01/09/2008

Medical Identifiers

Medical identifiers for Robert H Nicholson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659481885	NPI	-	NPPES
111690000	Medicaid	ME

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	007644 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert H Nicholson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert H Nicholson, MD Po Box 66, Skowhegan, ME 04976 Ph: (207) 474-8850	Robert H Nicholson, MD 56 Main Street, Skowhegan, ME 04976 Ph: (207) 474-8850

News Archive

Idera to present data from Phase 2 trial of IMO-3100 in patients with psoriasis at IID 2013

Idera Pharmaceuticals today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index scores in patients with moderate to severe plaque psoriasis following four weeks of treatment with the Toll-like Receptor antagonist IMO-3100.

Viewpoints: HHS officials must tell Congress, citizens what is happening to marketplaces; 'rate shock' didn't materialize; problems with medical credit cards

The Affordable Care Act's botched rollout has stunned its media cheering section, and it even seems to have surprised the law's architects. The problems run much deeper than even critics expected, and whatever federal officials, White House aides and outside contractors are doing to fix them isn't working. But who knows? ... Health and Human Services Secretary Kathleen Sebelius is even refusing to testify before the House Energy and Commerce Committee in a hearing this coming Thursday. ... The department is also refusing to make available lower-level officials who might detail the source or sources of this debacle (10/18).

Research sheds new light on central nervous system

Research by Renee Theiss, Jason Kuo and C J Heckman, which has just been published in The Journal of Physiology, throws light on how information is processed in the Central Nervous System (CNS) to drive movement.

New smart seat cushion may relieve painful pressure ulcers for wheelchair users

Modern-day wheelchairs provide a full range of mobility solutions to those who cannot walk, but many users still battle an unwanted side effect: painful ulcers caused by sitting for long periods in the same position.

Coronary procedure adds no benefit over 'optimal medical therapy' alone

Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone, according to study results presented at the 56th Annual Scientific Session of the American College of Cardiology in New Orleans, and published online in the New England Journal of Medicine.

Robert H Nicholson, MD - Ophthalmology in Skowhegan, ME